Health
Opioid Settlements: Some Lessons Learned from Big Tobacco
In September 2019, Purdue Pharma (Purdue) announced its agreement in principle on a framework for a “landmark” opioid litigation settlement worth, by Purdue’s account, an estimated $10 billion. As proposed, the agreement would settle claims brought by 24 attorneys general, five U.S. territories and the Plaintiffs’ Executive Committee in the opioid Multidistrict Litigation (MDL).